Literature DB >> 8686740

Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239.

V G Sasseville1, Z Du, L V Chalifoux, D R Pauley, H L Young, P K Sehgal, R C Desrosiers, A A Lackner.   

Abstract

The molecularly cloned virus known as SIVmac239/YEnef causes extensive lymphocyte activation in unstimulated peripheral mononuclear cell cultures and induces an acute disease syndrome in macaque monkeys. Here we describe the histopathological and immunophenotypic changes and viral localization in peripheral lymph nodes, spleen, and gastrointestinal tract (including the gut-associated lymphoid tissue (GALT) in rhesus monkeys inoculated with SIVmac239/YEnet beginning at day 3 postinoculation (pi). The findings are compared with those of rhesus monkeys inoculated with the same dose of parental SIVmac239. Histopathological examination of peripheral lymphoid tissue and GALT demonstrated marked hyperplasia of T-cell-dependent regions and involution of germinal centers as early as day 7 pi. The most striking lesions were multifocal areas of lymphohistiocytic gastroenteritis and colitis. Cellular infiltrates peaked between day 7 and 14 pi and were composed primarily of CD3+ T lymphocytes and HAM-56+ monocyte/macrophages. Many of these inflammatory cells were also strongly immunoreactive for teh nuclear proliferation antigen Ki-67. Despite the presence of severe gastrointestinal pathology by day 7 pi, no significant difference in the numbers of virus-positive cells in the gastrointestinal tract was observed between these animals and SIVmac239-infected animals examined at the same time point. However, the distribution of virus in the gastrointestinal tract was markedly different, with virus localized to lymphoid nodules of GALT in SIVmac239-infected animals and restricted to areas of lymphohistiocytic gastroenteritis and colitis in animals infected with SIVmac239/YEnef. Our data indicate that the acute disease syndrome induced by SIVmac239/YEnef is not simply related to increased viral replication in the gastrointestinal tract but is likely due to inappropriate virus-induced T lymphocyte activation and proliferation in GALT and subsequent mucosal destruction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686740      PMCID: PMC1865222     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo.

Authors:  A Hamann; D P Andrew; D Jablonski-Westrich; B Holzmann; E C Butcher
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

Review 2.  Pathology of simian immunodeficiency virus induced disease.

Authors:  A A Lackner
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

3.  Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.

Authors:  J S Gibbs; D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1994-04       Impact factor: 2.205

4.  Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.

Authors:  M Barbareschi; S Girlando; F M Mauri; S Forti; C Eccher; F A Mauri; R Togni; P Dalla Palma; C Doglioni
Journal:  Am J Clin Pathol       Date:  1994-08       Impact factor: 2.493

5.  Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.

Authors:  S C Dollard; S Gummuluru; S Tsang; P N Fultz; S Dewhurst
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells.

Authors:  L Chakrabarti; P Isola; M C Cumont; M A Claessens-Maire; M Hurtrel; L Montagnier; B Hurtrel
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction.

Authors:  C Heise; C J Miller; A Lackner; S Dandekar
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

8.  Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.

Authors:  A A Lackner; P Vogel; R A Ramos; J D Kluge; M Marthas
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

9.  Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques.

Authors:  D L Birx; M G Lewis; M Vahey; K Tencer; P M Zack; C R Brown; P B Jahrling; G Tosato; D Burke; R Redfield
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

Review 10.  Unique lentivirus--host interactions: SIVsmmPBj14 infection of macaques.

Authors:  P N Fultz; P M Zack
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

View more
  15 in total

1.  Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection.

Authors:  R S Veazey; M C Gauduin; K G Mansfield; I C Tham; J D Altman; J D Lifson; A A Lackner; R P Johnson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Costimulatory pathways in lymphocyte proliferation induced by the simian immunodeficiency virus SIVsmmPBj14.

Authors:  L Whetter; F J Novembre; M Saucier; S Gummuluru; S Dewhurst
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  Effects of HIV-1 Tat on enteric neuropathogenesis.

Authors:  Joy Ngwainmbi; Dipanjana D De; Tricia H Smith; Nazira El-Hage; Sylvia Fitting; Minho Kang; William L Dewey; Kurt F Hauser; Hamid I Akbarali
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

5.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Localization of productively infected cells in the spleen and Peyer's patches of rhesus macaques during acute infection with SIVmac239Δnef-enhanced green fluorescent protein.

Authors:  Gui-Bo Yang; Louis Alexander; Pyone Aye; Xavier Alvarez; Ronald C Desrosiers; Andrew A Lackner
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08       Impact factor: 2.205

7.  Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus.

Authors:  W Luo; B M Peterlin
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.

Authors:  W Zou; A A Lackner; M Simon; I Durand-Gasselin; P Galanaud; R C Desrosiers; D Emilie
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis.

Authors:  Juan T Borda; Xavier Alvarez; Ivanela Kondova; Pyone Aye; Meredith A Simon; Ronald C Desrosiers; Andrew A Lackner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques.

Authors:  Karol Sestak; Christopher K Merritt; Juan Borda; Elizabeth Saylor; Shelle R Schwamberger; Frank Cogswell; Elizabeth S Didier; Peter J Didier; Gail Plauche; Rudolf P Bohm; Pyone P Aye; Pavel Alexa; Richard L Ward; Andrew A Lackner
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.